KMPharmaceutical Co Ltd
KOSDAQ:225430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KMPharmaceutical Co Ltd
KOSDAQ:225430
|
KR |
|
SEB SA
F:GRB0
|
FR |
|
T
|
Thantawan Industry PCL
SET:THIP
|
TH |
|
Molecular Partners AG
SIX:MOLN
|
CH |
|
Agat Ejendomme A/S
F:2TD
|
DK |
|
DEV Information Technology Ltd
NSE:DEVIT
|
IN |
|
Multiconsult ASA
OSE:MULTI
|
NO |
|
S
|
Safe Fertility Group PCL
SET:SAFE
|
TH |
|
St Barbara Ltd
ASX:SBM
|
AU |
|
A
|
Appian Corp
F:910
|
US |
|
P
|
Panasonic Holdings Corp
F:MAT1
|
JP |
|
Nomura Micro Science Co Ltd
F:Q64
|
JP |
|
I
|
Indorama Ventures PCL
SET:IVL
|
TH |
|
M
|
Manhattan Gold Corporation Ltd
F:32U
|
AU |
|
H
|
Halliburton Co
DUS:HAL
|
US |
|
S
|
Semperit Holding AG
VSE:SEM
|
AT |
|
International Prospect Ventures Ltd
XTSX:IZZ
|
CA |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
|
H
|
Home Product Center PCL
SET:HMPRO
|
TH |
Shareholder Yield
Current shareholder yield for KMPharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
KMPharmaceutical Co Ltd
| Average Annual Return | -38.5% |
| Standard Deviation of Annual Returns | 20.77% |
| Max Drawdown | -96% |
| Market Capitalization | 3.9B KRW |
| Shares Outstanding | 5 580 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
KMPharmaceutical Co Ltd's latest stock split occurred on May 19, 2026
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, KMPharmaceutical Co Ltd traded at 517 per share. Afterward, the share price was about 2335.
The adjusted shares began trading on May 19, 2026. This was stock split number 2 in KMPharmaceutical Co Ltd's history, following the previous one in Oct 16, 2020.